Maria E. Lund
75 Talavera Road
Macquarie Park, NSW 2113, Australia
Macquarie Park, NSW 2113, Australia
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 18 publications
Pharmacokinetics and Biodistribution of 89Zr-Miltuximab and Its Antibody Fragments as Glypican-1 Targeting Immuno-PET Agents in Glioblastoma.
Journal: Molecular pharmaceutics
Published: January 05, 2023
The parasite-derived peptide FhHDM-1 activates the PI3K/Akt pathway to prevent cytokine-induced apoptosis of β-cells.
Journal: Journal of molecular medicine (Berlin, Germany)
Published: May 11, 2021
Safety and tolerability of Miltuximab® - a first in human study in patients with advanced solid cancers.
Journal: Asia Oceania journal of nuclear medicine & biology
Published: February 16, 2021
Radioimmunotherapy for solid tumors: spotlight on Glypican-1 as a radioimmunotherapy target.
Journal: Therapeutic advances in medical oncology
Published: December 10, 2020
Glypican-1 as a target for fluorescence molecular imaging of bladder cancer.
Journal: International journal of urology : official journal of the Japanese Urological Association
Published: November 12, 2020
The feasibility of Miltuximab®-IRDye700DX-mediated photoimmunotherapy of solid tumors.
Journal: Photodiagnosis and photodynamic therapy
Published: May 12, 2020
The Role of Glypican-1 in the Tumour Microenvironment.
Journal: Advances in experimental medicine and biology
Published: April 09, 2020
Fasciola hepatica hijacks host macrophage miRNA machinery to modulate early innate immune responses.
Fasciola hepatica hijacks host macrophage miRNA machinery to modulate early innate immune responses.
Journal: Scientific reports
Published: April 03, 2020
Detection of glypican-1 (GPC-1) expression in urine cell sediments in prostate cancer.
Journal: PloS one
Published: December 27, 2017
Last Updated: 09/26/2026